Advertisement

ZYXI

Zynex, Inc.

Healthcare · USD

Set alert

Price alert · ZYXI

All alert types
0.13 USD 0.00 0.00%
As of Apr 2, 2026 Extended hours 0.13 +4.00%
Bid
0.13 × 2
Ask
0.13 × 2
0.125 Day range 0.125
7.15 52-week range 13.77
YTD
-98.44%
1 year
-98.48%
Open
0.125
Prev close
0.125
Mkt cap
261.77M
Vol
274.57K
Avg vol
90.03K
EPS
0.14
P/E
58.71
Div yield
0.00%
More statistics
Low
0.125
High
0.125
Forward P/E
17.13
Beta
0.54
Short ratio
54.23
Inst. own
28.01%
Dividend
0.00
Ex-div date
Jan 4, 2022
Earnings
Nov 30, 2019
50-d avg
8.33
200-d avg
9.39
1y target
17.50

2Y chart

Chart tools
Interval
ZYXI two-year price chart0.063.486.9110.313.8Dec 23May 24Oct 24Mar 25Aug 25Dec 25

Key statistics

Market cap
261.77M
Enterprise value
299.78M
Trailing P/E
58.71
Forward P/E
17.13
PEG ratio
0.00
Price / sales
1.35
Price / book
7.31
EPS (TTM)
0.14
Beta
0.54
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
2.49%
Revenue (TTM)
193.66M
Revenue growth
0.10%
Free cash flow
19.76M
Total cash
37.63M
Total debt
74.68M
Return on equity
10.22%
Shares outstanding
31.85M
Short % of float
30.88%
50-day average
8.33
200-day average
9.39

Analyst view

Consensus: none

Price target (mean) 17.50 +13900.0% upside
Target (low)
11.00
Target (mean)
17.50
Target (high)
24.50
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 30, 2019

Expected Nov 30, 2019. Consensus EPS estimate 0.09.

Earnings history

Financials — quick view

All financials
ZYXI Revenue — quarterly 13.36M
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025
ZYXI Net income — quarterly -42.91M
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025
ZYXI EPS — quarterly -1.42
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025

Earnings

ZYXI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 30, 2019Dec 1, 20100.00———
Nov 10, 2016Sep 1, 20160.000.02——
Aug 22, 2016Jun 1, 20160.00-0.01——
May 19, 2016Mar 1, 20160.00-0.01——
Mar 31, 2016Dec 1, 20150.00-0.04——
Nov 17, 2015Sep 1, 20150.00-0.01——

Upgrades / downgrades

ZYXI analyst upgrades and downgrades
DateFirmActionFromTo
Dec 6, 2024HC Wainwright & Co.reitBuyBuy
Oct 25, 2024HC Wainwright & Co.mainBuyBuy
Oct 8, 2024RBC CapitalmainOutperformOutperform
Sep 4, 2024HC Wainwright & Co.reitBuyBuy
Jul 26, 2024RBC CapitalmainOutperformOutperform
Jul 26, 2024HC Wainwright & Co.mainBuyBuy

About Zynex, Inc.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Sector
Healthcare
Industry
Medical Distribution
Country
United States
Website
zynex.com

News

Your note

Sign in to keep a note on ZYXI — it syncs with the Stock Master app.

Insider holders

ZYXI insider holders
InsiderRelationLatest transactionDateShares held
CRESS MICHAEL DDirectorStock Award(Grant)May 15, 202422,587
DISBROW JOSHUA R.DirectorPurchaseJul 28, 202472,000
LUCSOK ANNAChief Operating OfficerStock Award(Grant)Oct 28, 202496,137
MICHAELS BARRY DDirectorStock Award(Grant)May 15, 202422,587
MOORHEAD DANIEL JChief Financial OfficerStock Award(Grant)Dec 4, 2024102,118
SANDGAARD THOMASChief Executive OfficerSaleNov 13, 202414,603,700

Institution ownership

ZYXI institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc3.65%1,178,1069.68MSep 29, 2024
Blackrock Inc.3.63%1,171,7909.63MSep 29, 2024
Hotchkis & Wiley Capital Management, LLC2.32%746,3806.14MSep 29, 2024
Nantahala Capital Management, LLC1.52%490,0004.03MSep 29, 2024
Geode Capital Management, LLC1.32%425,5093.50MSep 29, 2024
State Street Corporation1.17%378,0303.11MSep 29, 2024

Fund ownership

ZYXI fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.28%733,8086.03MSep 29, 2024
iShares Russell 2000 ETF1.16%372,5203.06MOct 30, 2024
Vanguard Extended Market Index Fund0.94%303,6302.50MSep 29, 2024
Hotchkis and Wiley Small Cap Diversified Value Fund0.63%202,2001.66MSep 29, 2024
Royce Micro-Cap Fund0.54%174,0881.43MSep 29, 2024
Fidelity Small Cap Index Fund0.48%155,0621.27MAug 30, 2024
Advertisement